Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · with Johns Hopkins University · NCT04597372
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 154
- US sites recruiting
- 1
- Study start
- November 3, 2021
- Record last updated
- March 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Being studied: Tamsulosin; Placebo
Conditions: Urinary Retention Postoperative
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years or older
- willing and able to provide informed consent
- postoperative urinary retention as defined by a failed RGVT prior to hospital discharge
- Ability to speak and read English
- Tolerate pill ingestion
Exclusion Criteria
- allergy/intolerance to Tamsulosin or sulfa drugs
- preoperative history of urinary retention as defined by preoperative post void residual of >150mL
- current use of alpha antagonist medication for hypertension
- severe dementia
- end stage renal or liver disease
- history of severe heart failure or major cardiovascular event in the last 6 months
Recruiting US locations
West Penn Hospital
Pittsburgh, PA 15224
Site contact: AHN Clinical Trials Contact · (412)-330-6151 · clinicaltrials@ahn.org
Study contacts (from the official record)
- Lindsay Turner · (412)-330-4567 · lindsay.turner@AHN.ORG
- AHN Clinical Trials Contact · (412)-330-4567 · clinicaltrials@ahn.org
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only